logo.jpg
Zusammenarbeit von Addex und Merck & Co. zur Entwicklung von Medikamenten bei Parkinson
December 03, 2007 01:30 ET | Addex Therapeutics
Das Ziel der Zusammenarbeit ist eine nicht-dopaminerge Herangehensweise bei der Behandlung der Parkinsonkrankheit   Addex veranstaltet heute um 17:00 Uhr MEZ (11:00 Uhr EDT) einen Webcast...
logo.jpg
Addex and Merck & Co., Inc. Collaborate to Develop Drugs for Parkinson's Disease
December 03, 2007 01:30 ET | Addex Therapeutics
Collaboration Targets a Non-Dopaminergic Approach to Treating Parkinson's Disease   Addex to Host Webcast and Conference Call Today at 5:00 pm CET (11:00 am EST)   Geneva, Switzerland -...
logo.jpg
Addex Webcast and Conference Call on Monday
November 30, 2007 13:38 ET | Addex Therapeutics
PRESS...
logo.jpg
Addex Presents ADX10059 GERD Data at Conference
October 29, 2007 07:33 ET | Addex Therapeutics
PRESS RELEASE   29 October 2007   English Version in PDF Format French Version in PDF Format  German Version in PDF Format    Paris, France - Allosteric...
logo.jpg
ADX10061 Phase IIa Smoking Cessation Data
October 01, 2007 01:00 ET | Addex Therapeutics
PRESS...
logo.jpg
Addex Pharmaceuticals appoints Head of ADME/PK
August 17, 2007 01:00 ET | Addex Therapeutics
PDF versionGeneva, Switzerland, 17 August 2007 - Allosteric modulation company Addex Pharmaceuticals Ltd announced today that Bruno Bournique has been appointed Head of Absorption,...
logo.jpg
Corrected Version: Addex Pharmaceuticals First Half 2007 Financial Results
July 25, 2007 02:59 ET | Addex Therapeutics
Addex raised CHF137 million in IPO ADX10059 shows efficacy in GERD & Migraine   Conference call & webcast at 15:30 CEST (9:30am EDT) Corrected version   English Release...
logo.jpg
Addex Pharmaceuticals First Half 2007 Financial Results
July 25, 2007 01:00 ET | Addex Therapeutics
Addex raised CHF137 million in IPO ADX10059 shows efficacy in GERD & Migraine   Conference call & webcast at 15:30 CEST (9:30am EDT)   English Release (PDF)   German...